Alpha Teknova, Inc. (TKNO)
USD 5.67
(1.43%)
USD 5.67
(1.43%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -35.56 Million USD | -5.69% |
| 2022 | -28.85 Million USD | -140.32% |
| 2021 | -12 Million USD | -357.52% |
| 2020 | 4.66 Million USD | 351.24% |
| 2019 | -1.85 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -6.68 Million USD | 23.05% |
| 2024 Q2 | -5.1 Million USD | 23.72% |
| 2023 Q2 | -6.99 Million USD | 21.79% |
| 2023 Q1 | -8.94 Million USD | 10.97% |
| 2023 FY | -30.49 Million USD | -5.69% |
| 2023 Q4 | -8.68 Million USD | 0.83% |
| 2023 Q3 | -8.76 Million USD | -25.23% |
| 2022 Q2 | -6.62 Million USD | -13.4% |
| 2022 FY | -28.85 Million USD | -140.32% |
| 2022 Q1 | -5.84 Million USD | -22.57% |
| 2022 Q3 | 10.27 Million USD | 255.03% |
| 2022 Q4 | -10.04 Million USD | -197.82% |
| 2021 Q4 | -4.76 Million USD | -22.61% |
| 2021 Q1 | -828 Thousand USD | -204.15% |
| 2021 FY | -12 Million USD | -357.52% |
| 2021 Q2 | -2.52 Million USD | -205.07% |
| 2021 Q3 | -3.88 Million USD | -53.92% |
| 2020 Q1 | 1.01 Million USD | 0.0% |
| 2020 FY | 4.66 Million USD | 351.24% |
| 2020 Q4 | 795 Thousand USD | -63.06% |
| 2020 Q3 | 2.15 Million USD | 205.68% |
| 2020 Q2 | 704 Thousand USD | -30.43% |
| 2019 FY | -1.85 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 121.3% |
| Embecta Corp. | 221.5 Million USD | 116.056% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 175.713% |
| Dynavax Technologies Corporation | -37.02 Million USD | 3.956% |
| Esperion Therapeutics, Inc. | -155.56 Million USD | 77.139% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 140.562% |
| PainReform Ltd. | -9.58 Million USD | -271.066% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | -135.485% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -643.172% |
| SCYNEXIS, Inc. | 72.66 Million USD | 148.938% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -1313.914% |
| Cosmos Health Inc. | -21.83 Million USD | -62.9% |
| Journey Medical Corporation | -2.07 Million USD | -1615.533% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -643.172% |
| Safety Shot Inc | -12.18 Million USD | -191.879% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 77.687% |
| Bright Green Corporation | -8.89 Million USD | -299.972% |
| Procaps Group, S.A. | 38.97 Million USD | 191.25% |
| Theratechnologies Inc. | -10.62 Million USD | -234.648% |
| Harrow Health, Inc. | 580 Thousand USD | 6231.552% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -656.499% |
| Biofrontera Inc. | -22.67 Million USD | -56.824% |
| DURECT Corporation | -36.88 Million USD | 3.581% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -574.948% |
| Cronos Group Inc. | -81.37 Million USD | 56.298% |
| OptiNose, Inc. | -22.74 Million USD | -56.335% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 117.013% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 9.169% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 381.531% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 383.936% |
| Guardion Health Sciences, Inc. | -4.33 Million USD | -720.12% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -472.598% |
| Radius Health, Inc. | -3.92 Million USD | -806.064% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -908.372% |
| ProPhase Labs, Inc. | -21.61 Million USD | -64.544% |
| Phibro Animal Health Corporation | 53.31 Million USD | 166.704% |
| Procaps Group S.A. | 52.32 Million USD | 167.967% |
| Alvotech | -354.86 Million USD | 89.978% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -317.259% |
| Viatris Inc. | 766.2 Million USD | 104.641% |
| Rockwell Medical, Inc. | -6.67 Million USD | -433.178% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -576.875% |
| SIGA Technologies, Inc. | 83.62 Million USD | 142.529% |
| Tilray Brands, Inc. | -174.74 Million USD | 79.649% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 481.127% |
| Shineco, Inc. | -17.06 Million USD | -108.387% |
| PetIQ, Inc. | 60.01 Million USD | 159.257% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -650.793% |
| Incannex Healthcare Limited | -30.04 Million USD | -18.382% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 114.174% |
| Alimera Sciences, Inc. | -1.47 Million USD | -2317.607% |
| Silver Spike Investment Corp. | 7.34 Million USD | 584.502% |
| Assertio Holdings, Inc. | -243.53 Million USD | 85.397% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -503.542% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | -161.159% |
| Clever Leaves Holdings Inc. | -15.59 Million USD | -128.056% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -77.371% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 74.201% |
| Hempacco Co., Inc. | -8.81 Million USD | -303.562% |
| Talphera, Inc. | -16.88 Million USD | -110.569% |
| Alvotech | -354.86 Million USD | 89.978% |
| Eagle Pharmaceuticals, Inc. | 53.45 Million USD | 166.53% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 109.753% |
| Currenc Group, Inc. | -6.64 Million USD | -435.121% |
| Kamada Ltd. | 10.06 Million USD | 453.368% |
| Indivior PLC | -4 Million USD | -789.075% |
| Evoke Pharma, Inc. | -7.43 Million USD | -378.583% |
| Flora Growth Corp. | -50.35 Million USD | 29.374% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | -77.371% |
| Evolus, Inc. | -49.23 Million USD | 27.766% |
| HUTCHMED (China) Limited | 18.37 Million USD | 293.54% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 118.053% |
| Akanda Corp. | -10.05 Million USD | -253.812% |